May 15, 2020 / 10:35 AM / 19 days ago

BRIEF-Novus Therapeutics Reports Q1 2020 Financial Results

May 15 (Reuters) - Novus Therapeutics Inc:

* NOVUS THERAPEUTICS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS

* Q1 LOSS PER SHARE $0.47

* TOPLINE RESULTS OF OP0201 PHASE 2A CLINICAL TRIAL IN ACUTE OTITIS MEDIA (STUDY C-006) ARE EXPECTED IN EARLY JUNE 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below